SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PARANOID! TIRED OF TALKING TO YOURSELF? LET'S TALK(TTP)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mike head who wrote (69)5/30/1998 10:36:00 PM
From: Arthur Radley  Read Replies (1) of 626
 
Mike,
As I gather more info on Titan, the more excited I get. It is unbelievable that they have a pipeline that includes multiple products in late-stage clinical trials addressing cancer and neurological diseases, two areas(sadly) that have high growth potential. Their relationship with Novartis to bring Iloperidone to the market will generate enormous revenue for Titan. Before the year is out they should sign partnerships for their cancer vaccines and this will certainly(IMO) break Titan from the ranks of a $5.00 stock. Anyone interested in this stock should call their PR firm and get the stockholder packet....Lippert/Heilshorn and Assoc. 212/838-3777. The phone call could be the best spent money ever for anyone interested in a stock with a future.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext